Imagion Biosystems Ltd. IBX
ASX · Australia · Health Technology
AUD 0.007000-0.00 (-12.50%)
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
MELBOURNE, Australia, September 14, 2026--Imagion Biosystems, Ltd. (ASX: IBX) announced it will resume MagSense® Nanoparticle manufacturing capabilities ahead of its Phase 1b/2 clinical trial and potential commercialization. The company has contracted nanoComposix, a nanoparticle Contract Development and Manufacturing Organization (CDMO). Under the signed agreement, Imagion will provide the proprietary nanoparticle synthesis equipment, software and procedures required for the CDMO to start manuf
MELBOURNE, Australia, June 25, 2026--IBX announced that it has secured firm commitments for AU$3.75M (US$2.59M) in new capital following the FDA’s clearance of IND for a Phase 2 trial.
MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 93rd Emerging Growth Conference on June 10 & 11, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 90th Emerging Growth Conference on February 25 & 26, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting com
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.